SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : AMLN (DIABETES DRUGS) -- Ignore unavailable to you. Want to Upgrade?

To: celeryroot.com who wrote (1590)3/24/1999 10:55:00 AM
From: J Gunn  Read Replies (1) | Respond to of 2173
 
Good for them. Not quite the same as having Johnson & Johnson behind you however.



To: celeryroot.com who wrote (1590)4/2/1999 3:24:00 PM
From: Dr. John M. de Castro  Read Replies (1) | Respond to of 2173
 
Here's the Edgar filing on the new financing.

freeedgar.com

I looked at it quickly to determine if this might be a floorless convertible. However, my reading indicates that this is a legitimate righteous financing agreement. Getting terms like these in todays biotech investing environment and in AMLN's weakened condition is excellent.

John de C


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News